The National Gene Vector Biorepository (NGVB) is a resource for academic investigators and others conducting gene therapy research.

Efforts in the NGVB are focused in four areas:

  1. Archiving and Testing Services
  2. Insertional Site Analysis
  3. Pharmacology and Toxicology Resources
  4. Reagent Repository.

The databases and educational resources are open to everyone. Other services are limited to gene therapy investigators working in academic or other non-profit organizations. Please see About the NGVB for eligibility requirements.

What's New
The pharmtox database now includes non-GLP "Proof of Concept" studies submitted to the FDA in support of IND submission. Click here for details.

See us at the American Society of Gene & Cell Therapy 20th Annual Meeting Washington DC
May 10-13 2017
Visit us at Booth 303

NEED ASSISTANCE WITH MOVING YOUR GENE AND CELL THERAPY PROJECT TO CLINIC?

The Growing Gene and Cell Therapy (GGACT)

A collaboration between Boston Children's Hospital, Cincinnati Children's Hospital Medical Center, and the University of California Los Angeles, was established in 2016 with funding from NIH NCATS. We aim to support investigators to rapidly translate complex gene and cell therapies to early phase, investigator-initiated clinical trials. For information and available services please visit our website:

http://www.ggact.org/for-investigators/services-available/

This site may be intermittently unavailable on the first Tuesday of each month from 8am to 5pm EDT for regularly scheduled server maintenance.